KING Net Debt vs Intangible Assets Analysis
| KG Stock | 28.61 0.03 0.10% |
KING PHARMACEUTICALS financial indicator trend analysis is infinitely more than just investigating KING PHARMACEUTICALS INC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether KING PHARMACEUTICALS INC is a good investment. Please check the relationship between KING PHARMACEUTICALS Net Debt and its Intangible Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in KING PHARMACEUTICALS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
Net Debt vs Intangible Assets
Net Debt vs Intangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of KING PHARMACEUTICALS INC Net Debt account and Intangible Assets. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between KING PHARMACEUTICALS's Net Debt and Intangible Assets is 0.42. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of KING PHARMACEUTICALS INC, assuming nothing else is changed. The correlation between historical values of KING PHARMACEUTICALS's Net Debt and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of KING PHARMACEUTICALS INC are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Net Debt i.e., KING PHARMACEUTICALS's Net Debt and Intangible Assets go up and down completely randomly.
Correlation Coefficient | 0.42 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Intangible Assets
Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.Most indicators from KING PHARMACEUTICALS's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into KING PHARMACEUTICALS INC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in KING PHARMACEUTICALS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. The current Selling General Administrative is estimated to decrease to about 1.2 M. The current Tax Provision is estimated to decrease to about 16.5 K
| 2010 | 2011 | 2024 | 2025 (projected) | Cost Of Revenue | 142.5M | 3.5M | 3.4M | 3.2M | Research Development | 18.7M | 98.7M | 113.4M | 214.6M |
KING PHARMACEUTICALS fundamental ratios Correlations
Click cells to compare fundamentals
KING PHARMACEUTICALS Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in KING PHARMACEUTICALS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of KING PHARMACEUTICALS. If investors know KING will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about KING PHARMACEUTICALS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.03 |
The market value of KING PHARMACEUTICALS INC is measured differently than its book value, which is the value of KING that is recorded on the company's balance sheet. Investors also form their own opinion of KING PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is KING PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because KING PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect KING PHARMACEUTICALS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between KING PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine if KING PHARMACEUTICALS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, KING PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.